Nodular thyroid disease laboratory findings

Revision as of 14:12, 19 September 2012 by Raviteja Reddy Guddeti (talk | contribs) (Created page with "__NOTOC__ {{Nodular thyroid disease}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Nodular thyroid disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nodular thyroid disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Fine Needle Aspiration

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nodular thyroid disease laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nodular thyroid disease laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nodular thyroid disease laboratory findings

CDC on Nodular thyroid disease laboratory findings

Nodular thyroid disease laboratory findings in the news

Blogs on Nodular thyroid disease laboratory findings

Directions to Hospitals Treating Nodular thyroid disease

Risk calculators and risk factors for Nodular thyroid disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Laboratory Findings

  • The thyroid stimulating hormone (TSH) is the most important test, as it can identify patients with unsuspected thyrotoxicosis. The next step would likely be a scan. Serum calcitonin should be measured when medullary carcinoma is suspected, however this is controversial and expensive.

References


Template:WikiDoc Sources